- Report
- August 2025
North America
From €1873EUR$2,095USD£1,629GBP
€3567EUR$3,990USD£3,103GBP
- Report
- August 2025
Europe
From €1873EUR$2,095USD£1,629GBP
€3567EUR$3,990USD£3,103GBP
- Report
- August 2025
Middle East
From €1873EUR$2,095USD£1,629GBP
€3567EUR$3,990USD£3,103GBP
- Report
- August 2025
Asia Pacific
From €1873EUR$2,095USD£1,629GBP
€3567EUR$3,990USD£3,103GBP
- Report
- August 2025
United Kingdom
From €1873EUR$2,095USD£1,629GBP
€3567EUR$3,990USD£3,103GBP
- Report
- August 2025
China
From €1873EUR$2,095USD£1,629GBP
€3567EUR$3,990USD£3,103GBP
- Report
- August 2025
United States
From €1873EUR$2,095USD£1,629GBP
€3567EUR$3,990USD£3,103GBP
- Report
- October 2023
- 80 Pages
Russia
From €1341EUR$1,500USD£1,167GBP
- Report
- October 2023
- 80 Pages
Poland
From €1341EUR$1,500USD£1,167GBP
- Report
- October 2023
- 80 Pages
Russia
From €1341EUR$1,500USD£1,167GBP
- Report
- October 2023
- 80 Pages
Poland
From €1341EUR$1,500USD£1,167GBP
- Report
- October 2023
- 100 Pages
Africa
From €1788EUR$2,000USD£1,556GBP
- Report
- June 2025
- 119 Pages
Brazil
From €5359EUR$5,995USD£4,663GBP
- Report
- June 2025
- 119 Pages
Mexico
From €5359EUR$5,995USD£4,663GBP
- Report
- June 2025
- 124 Pages
Japan
From €5359EUR$5,995USD£4,663GBP
- Report
- June 2025
- 132 Pages
China
From €5359EUR$5,995USD£4,663GBP
- Report
- June 2025
- 119 Pages
Russia
From €5359EUR$5,995USD£4,663GBP
- Report
- June 2025
- 122 Pages
Spain
From €5359EUR$5,995USD£4,663GBP
- Report
- February 2025
- 90 Pages
India, Russia, Brazil, ... India, Russia, Brazil, China
From €5359EUR$5,995USD£4,663GBP
- Report
- August 2024
- 23 Pages
Brazil
From €4465EUR$4,995USD£3,885GBP

The Infusions and Injectables market is a segment of the pharmaceutical industry that focuses on the production and distribution of drugs that are administered through intravenous (IV) or intramuscular (IM) injections. These drugs are used to treat a variety of medical conditions, including cancer, diabetes, and autoimmune diseases. The market is highly competitive, with a number of large pharmaceutical companies vying for market share.
The market is divided into two main segments: branded and generic drugs. Branded drugs are typically more expensive than generic drugs, but they are often more effective and have fewer side effects. Generic drugs are typically cheaper, but they may not be as effective or have as many side effects.
Some of the major players in the Infusions and Injectables market include Pfizer, Merck, Novartis, Sanofi, and Johnson & Johnson. These companies are responsible for the production and distribution of a wide range of drugs, including cancer treatments, diabetes medications, and autoimmune therapies. Show Less Read more